MusclePharm Stock Forecast, Price & News

MusclePharm (OTCMKTS:MSLP) Frequently Asked Questions

What stocks does MarketBeat like better than MusclePharm?

Wall Street analysts have given MusclePharm a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but MusclePharm wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting MusclePharm?

MusclePharm saw a decline in short interest in the month of October. As of October 15th, there was short interest totaling 800 shares, a decline of 42.9% from the September 30th total of 1,400 shares. Based on an average trading volume of 22,400 shares, the short-interest ratio is presently 0.0 days.
View MusclePharm's Short Interest.

When is MusclePharm's next earnings date?

MusclePharm is scheduled to release its next quarterly earnings announcement on Monday, November 22nd 2021.
View our earnings forecast for MusclePharm.

How were MusclePharm's earnings last quarter?

MusclePharm Co. (OTCMKTS:MSLP) issued its quarterly earnings data on Monday, August, 16th. The company reported ($0.07) earnings per share (EPS) for the quarter. The firm had revenue of $14.91 million for the quarter. MusclePharm had a net margin of 2.26% and a negative trailing twelve-month return on equity of 5.24%.
View MusclePharm's earnings history.

How has MusclePharm's stock been impacted by COVID-19?

MusclePharm's stock was trading at $0.18 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MSLP shares have increased by 255.6% and is now trading at $0.64.
View which stocks have been most impacted by COVID-19.

Who are MusclePharm's key executives?

MusclePharm's management team includes the following people:

• Ryan Charles Drexler, Executive Chairman & Chief Executive Officer
• Sabina Rizvi, President & Chief Financial Officer

Who are some of MusclePharm's key competitors?

Some companies that are related to MusclePharm include Capricor Therapeutics (CAPR), Neptune Wellness Solutions (NEPT), Concert Pharmaceuticals (CNCE), Aptorum Group (APM), Abeona Therapeutics (ABEO), Aadi Bioscience (AADI), LifeVantage (LFVN), Cocrystal Pharma (COCP), Galecto (GLTO), Gain Therapeutics (GANX), Aileron Therapeutics (ALRN), Akari Therapeutics (AKTX), Celsion (CLSN), Tempest Therapeutics (TPST) and Moleculin Biotech (MBRX).
View all of MSLP's competitors.

What other stocks do shareholders of MusclePharm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MusclePharm investors own include Dalradian Resources (DALR), EVRAZ (EVRZF), Rent-A-Center (RCII), Avino Silver & Gold Mines (ASM), AdvanSix (ASIX), Accuray (ARAY), Apollo Global Management (APO), TD Ameritrade (AMTD), Alaska Communications Systems Group (ALSK) and Alnylam Pharmaceuticals (ALNY).

What is MusclePharm's stock symbol?

MusclePharm trades on the OTCMKTS under the ticker symbol "MSLP."

How do I buy shares of MusclePharm?

Shares of MSLP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MusclePharm's stock price today?

One share of MSLP stock can currently be purchased for approximately $0.64.

How much money does MusclePharm make?

MusclePharm has a market capitalization of $21.98 million and generates $64.44 million in revenue each year.

How many employees does MusclePharm have?

MusclePharm employs 27 workers across the globe.

What is MusclePharm's official website?

The official website for MusclePharm is www.musclepharm.com.

Where are MusclePharm's headquarters?

MusclePharm is headquartered at 4400 VANOWEN STREET, BURBANK CA, 80239.

How can I contact MusclePharm?

MusclePharm's mailing address is 4400 VANOWEN STREET, BURBANK CA, 80239. The company can be reached via phone at (800) 292-3909 or via email at [email protected].